Applied Therapeutics Says Pre-NDA Meeting To Be Held This Summer To Discuss Potential NDA Submission For AT-007
Portfolio Pulse from Bill Haddad
Applied Therapeutics announced that a pre-NDA meeting will be held this summer to discuss a potential NDA submission for AT-007.
July 25, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied Therapeutics' announcement of a pre-NDA meeting for AT-007 could potentially impact the company's stock.
The announcement of a pre-NDA meeting indicates progress in the development of AT-007. This could potentially lead to an increase in investor confidence and a positive impact on the company's stock in the short term.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100